Gene Expression-Based Classification of Non-Small Cell Lung Carcinomas and Survival Prediction
Figure 5
A 17 probe set signature predicts patient survival time.
Kaplan-Meier curves for A: 82 Erasmus MC NSCLC patients and B: 89 Duke University NSCLC patients fitted by their risk assignments based on the 17 probe set survival signature. The high- and low-risk groups differ significantly, indicated by the p-values. Grey bars indicate patients at last follow-up, still alive.